tiprankstipranks
Is INGN a Buy, Before Earnings?
PremiumPre-EarningsIs INGN a Buy, Before Earnings?
2M ago
William Blair upgrades Inogen to Outperform on Respironics exit
PremiumThe Fly
William Blair upgrades Inogen to Outperform on Respironics exit
2M ago
Inogen upgraded to Outperform from Market Perform at William Blair
PremiumThe Fly
Inogen upgraded to Outperform from Market Perform at William Blair
2M ago
Inogen backs FY23 revenue view $315M-$320M, consensus $317.11M
PremiumThe FlyInogen backs FY23 revenue view $315M-$320M, consensus $317.11M
5M ago
Inogen appoints Kevin Smith as CEO
PremiumThe Fly
Inogen appoints Kevin Smith as CEO
5M ago
Inogen reports Q3 adjusted EPS (36c), consensus (49c)
PremiumThe Fly
Inogen reports Q3 adjusted EPS (36c), consensus (49c)
6M ago
Inogen downgraded to Underweight from Neutral at JPMorgan
PremiumThe FlyInogen downgraded to Underweight from Neutral at JPMorgan
9M ago
Inogen sees FY23 revenue $315M-$320M, consensus $369.22M
PremiumThe Fly
Inogen sees FY23 revenue $315M-$320M, consensus $369.22M
9M ago
Inogen reports Q2 EPS (42c), consensus (59c)
PremiumThe Fly
Inogen reports Q2 EPS (42c), consensus (59c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100